WO2022139742A1 - Produit de soin de la peau renforçant la structure de la peau - Google Patents
Produit de soin de la peau renforçant la structure de la peau Download PDFInfo
- Publication number
- WO2022139742A1 WO2022139742A1 PCT/TR2021/051259 TR2021051259W WO2022139742A1 WO 2022139742 A1 WO2022139742 A1 WO 2022139742A1 TR 2021051259 W TR2021051259 W TR 2021051259W WO 2022139742 A1 WO2022139742 A1 WO 2022139742A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- skin care
- product according
- care product
- oil
- Prior art date
Links
- 238000005728 strengthening Methods 0.000 title claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 47
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 239000004480 active ingredient Substances 0.000 claims abstract description 29
- 230000001105 regulatory effect Effects 0.000 claims abstract description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 55
- 239000003921 oil Substances 0.000 claims description 36
- 235000019198 oils Nutrition 0.000 claims description 36
- 229940088594 vitamin Drugs 0.000 claims description 26
- 229930003231 vitamin Natural products 0.000 claims description 26
- 235000013343 vitamin Nutrition 0.000 claims description 26
- 239000011782 vitamin Substances 0.000 claims description 26
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 26
- 239000004094 surface-active agent Substances 0.000 claims description 23
- 239000003974 emollient agent Substances 0.000 claims description 20
- 239000003755 preservative agent Substances 0.000 claims description 20
- 230000003020 moisturizing effect Effects 0.000 claims description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 16
- 239000008158 vegetable oil Substances 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- 229930003571 Vitamin B5 Natural products 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- 229960002079 calcium pantothenate Drugs 0.000 claims description 8
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 8
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 8
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 claims description 8
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 8
- 239000011675 vitamin B5 Substances 0.000 claims description 8
- 235000009492 vitamin B5 Nutrition 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 235000019486 Sunflower oil Nutrition 0.000 claims description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 229940119170 jojoba wax Drugs 0.000 claims description 6
- 239000004006 olive oil Substances 0.000 claims description 6
- 235000008390 olive oil Nutrition 0.000 claims description 6
- 239000008159 sesame oil Substances 0.000 claims description 6
- 235000011803 sesame oil Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000002600 sunflower oil Substances 0.000 claims description 6
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 6
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 claims description 6
- 241000336315 Cistanche salsa Species 0.000 claims description 5
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 5
- 229920002774 Maltodextrin Polymers 0.000 claims description 5
- 241000263388 Orobanche rapum-genistae Species 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 229940035034 maltodextrin Drugs 0.000 claims description 5
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 5
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 claims description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 2
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 2
- 235000019493 Macadamia oil Nutrition 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 2
- 229930003537 Vitamin B3 Natural products 0.000 claims description 2
- 229930003756 Vitamin B7 Natural products 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 235000021302 avocado oil Nutrition 0.000 claims description 2
- 239000008163 avocado oil Substances 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- 235000021324 borage oil Nutrition 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 2
- 229940040102 levulinic acid Drugs 0.000 claims description 2
- 239000010469 macadamia oil Substances 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- 239000001944 prunus armeniaca kernel oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 229940058349 sodium levulinate Drugs 0.000 claims description 2
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 235000019160 vitamin B3 Nutrition 0.000 claims description 2
- 239000011708 vitamin B3 Substances 0.000 claims description 2
- 235000011912 vitamin B7 Nutrition 0.000 claims description 2
- 239000011735 vitamin B7 Substances 0.000 claims description 2
- 239000010497 wheat germ oil Substances 0.000 claims description 2
- 125000003201 pantothenic acid group Chemical group 0.000 claims 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 7
- 230000037307 sensitive skin Effects 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 52
- 239000000047 product Substances 0.000 description 43
- 206010036590 Premature baby Diseases 0.000 description 10
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 239000002075 main ingredient Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 244000005714 skin microbiome Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- -1 compounds sodium benzoate Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Definitions
- the subject of the invention relates to a skin care product, which enables to moisturize, meet the water requirement of, regulate the flora of and thus strengthen the structure of especially the sensitive skin of the babies delivered before completing their development in the mother's womb.
- the skin is the part of the body that protects the internal organs from the external mechanical, chemical and biological effects by separating the same from the external environment, assists with the regulation of the body temperature and water balance and is capable of self-repair by performing the production of collagen and protein.
- Stratum corneum epidermidis layer constitutes the outermost layer of the skin in a state of permanent contact with the external environment and enables, by maintaining the water content of the skin above 10% owing to the natural moisturizing factors it contains, the preservation of the flexible and elastic structure of the skin and of the natural flora of the skin that hosts the beneficial microorganisms.
- the waxy vernix layer which forms in the last trimester of pregnancy on the stratum corneum and contains a great number of beneficial compounds protective for the skin, including the antimicrobial compounds, is not either fully developed in the skin of the premature babies. Therefore, the skin of the premature babies is sensitive and vulnerable and prone to infection. For this reason, it is necessary to strengthen the skin of the premature babies by moisturizing, meeting the water requirement of and regulating the flora of the skin.
- the moisturizing products with soothing action are used for providing the care for the skin of the babies.
- such products due to the types and/or quantities of the chemical agents they contain, result in effects that are quite the contrary by irritating the skin and leading to the loss of natural moisturizing factors and water from the stratum corneum, the development of dryness and cracks in the skin and the disruption of the natural skin flora, in case they are applied to the sensitive and vulnerable skin of the premature babies.
- the skin care products are needed, which enable to strengthen the skin structure without irritating the skin and which are suitable for application on the sensitive skin of the premature babies as well.
- a skin care product which enables to generate the conditions ideal for the regulation of the moisture balance of the skin and the skin flora, meets the need for water, eliminates the risk for the development of infection and thus strengthens the skin structure, has been developed within the scope of the invention.
- the skin care product achieves said functions by means of its ingredients that are compatible with the skin pH of the babies as well, are natural and/or of natural origin and do not irritate the skin and said product is suitable for use in the care of the skin of the premature babies delivered before completing their development in the mother's womb.
- An object of the invention is to develop a skin care product, which enables to moisturize, meet the water requirement of, regulate the flora of and thus strengthen the structure of the skin of especially the premature babies delivered before completing their development in the mother's womb.
- Another object of the invention is to develop a skin care product, which, without causing irritation, strengthens the structure of the skin of the premature babies delivered before completing their development in the mother's womb, owing its preservative ingredient that is, unlike the conventional skin care products, compatible with the pH value of the skin of the babies and is natural and/or of natural origin.
- Another object of the invention is to develop a lotion having the features mentioned in the previous two objects of the invention.
- the subject of the invention relates to a skin care product, which enables to moisturize, meet the water requirement of, regulate the flora of and thus strengthen the structure of especially the sensitive skin of the babies delivered before completing their development in the mother's womb.
- the product according to the invention basically comprises an oil phase containing the oilsoluble ingredients, a water phase containing the water-soluble ingredients, and at least one active ingredient and/or active ingredient mixture providing the moisture balance of and regulating the flora of the skin.
- the oil phase basically contains at least one type of vegetable oil and at least one surfactant, which enables the water phase to homogeneously disperse in the oil phase and has a hydrophilic-lipophilic balance (H LB) value in the range of 3-8.
- the water phase contains water, at least one moisturizing agent, at least one pH regulating agent enabling the pH of the composition to be adjusted to a value in the range of 4-4.5 and at least one preservative agent being active at the pH values in the range of 4-4.5.
- the skin care product according to the invention comprises, in the oil phase, 1-8% by weight at least one type of vegetable oil and 0.5-7% by weight at least one surfactant with a HLB value of 3-8; and, in the water phase, 25-36% by weight water, 3-10% by weight at least one moisturizing agent, 0.1-0.5% by weight at least one pH regulating agent enabling the pH of the composition to be adjusted to a value in the range of 4-4.5 and 1-5% by weight at least one preservative agent being active at the pH values in the range of 4-4.5.
- composition according to the invention comprises the vegetable oil preferably at a ratio of 4-8% by weight.
- the product according to the invention comprises at least one surfactant with a HLB value of 3-8 at a ratio of 1.5-7% by weight.
- the product according to the invention comprises 0.1-1% by weight at least one active ingredient or active ingredient mixture.
- the product according to the invention comprises as the vegetable oil at least one oil selected from but not limited to olive oil, sunflower oil, sweet almond oil, jojoba oil, apricot kernel oil, avocado oil, sesame oil, macadamia oil, corn oil, wheat germ oil, safflower oil, borage oil and sea buckthorn oil.
- the product according to the invention comprises as the surfactant at least one type of nonionic surfactant with a hydrophilic-lipophilic balance (HLB) value in the range of 3-8.
- HLB hydrophilic-lipophilic balance
- the product according to the invention comprises as the surfactant at least one compound selected from but not limited to the compounds Polyglyceryl -2 Dipolyhydroxystearate, Polyglyceryl-3 Diisostearate, Polyglyceryl-2 Sesquiiisostearate, Polyglyceryl-3 Polyricinoleate and Glyceryl Oleate.
- the product according to the invention comprises two surfactants wherein said surfactants are preferably Polyglyceryl-2 Dipolyhydroxystearate preferably at a ratio of 1-5% by weight and preferably Polyglyceryl-3 Diisostearate preferably at a ratio of 0.5- 2% by weight.
- said surfactants are preferably Polyglyceryl-2 Dipolyhydroxystearate preferably at a ratio of 1-5% by weight and preferably Polyglyceryl-3 Diisostearate preferably at a ratio of 0.5- 2% by weight.
- the preservatives were examined in terms of their effects especially on the skin of the premature babies, whether or not they are natural or of natural origin, their solubility in water, the pH values at which they exhibit activity, their odor, and whether they cause color change in the finished product.
- the preservatives that are natural or of natural origin have high solubility in water, are active in the pH range of 4-4.5 also, are odorless or have a pleasant smell, and do not cause any undesirable color change in the finished product were determined.
- the product according to the invention comprises as the preservative agent at least one of the compounds sodium benzoate, benzoic acid, levulinic acid, benzyl alcohol, pentylene glycol, potassium sorbate and sodium levulinate.
- the composition according to the invention preferably comprises pentylene glycol as the preservative.
- the product according to the invention preferably comprises at least one of an active ingredient mixture containing maltodextrin and lactobacillus ferment as the active ingredients or an active ingredient mixture containing propanediol and broomrape (orobanche rapum) extract as the active ingredients.
- the product according to the invention comprises preferably at least one acid, preferably citric acid, as the pH regulating agent.
- the product according to the invention preferably comprises glycerin as the moisturizing agent.
- the product according to the invention comprises, in addition to the main ingredients, at least one emollient at a ratio of 3-25% by weight in the oil phase.
- the composition according to the invention preferably comprises at least one emollient at a ratio of 8-25% by weight.
- the product according to the invention comprises at least one compound preferably selected from but not limited to the compounds caprylic/capric triglyceride, coco caprylate/caprate, isopropyl myristate and isopropyl palmitate as the emollient.
- the product according to the invention comprises two emollients, said emollients preferably being caprylic/capric triglyceride preferably at a ratio of 5-15% by weight and coco caprylate/caprate preferably at a ratio of 3-10% by weight.
- the product according to the invention comprises, in addition to the main ingredients, at least one type of vitamin in the oil phase and/or at least one type of vitamin in the water phase, at a ratio of 0.1-3.5% by weight, preferably 0.6-3.5% by weight, based on the composition of the finished product.
- the product according to the invention comprises as said vitamin at least one vitamin preferably selected from but not limited to vitamin E (tocopherol acetate), vitamin B3, vitamin B5 (panthenol) and vitamin B7.
- the product according to the invention comprises two types of vitamin, i.e. preferably vitamin E preferably at a ratio of 0.1-1.5% by weight in the oil phase and preferably vitamin B5 preferably at a ratio of 0.5-2% by weight in the water phase.
- the product according to the invention comprises, in addition to the main ingredients, at least one type of gelling and viscosity increasing agent in the oil phase, preferably at a ratio of 0.5-2% by weight, wherein said agent is preferably zinc stearate.
- the product according to the invention comprises, in addition to the main ingredients, at least one type of agent for providing electrolytic medium and increasing stability, in the water phase, preferably at a ratio of 1-3% by weight, wherein said agent is preferably zinc sulphate heptahydrate.
- the product according to the invention comprises 25-36% by weight water, 4-8% by weight at least one vegetable oil, 3-10% by weight at least one moisturizing agent, 1.5-7% by weight at least one surfactant with a HLB value in the range of 3-8, 1-5% by weight preservative agent, 0.1-0.5% by weight pH regulating agent, 0.1-0.5% by weight active ingredient mixture, 0.5-2% by weight viscosity increasing agent in the oil phase, 1-3% by weight stability increasing agent in the water phase, 8-25% by weight emollient in the oil phase and 0.6-3.5% by weight vitamin.
- Said embodiment comprises 1-2% by weight sunflower oil, 1-2% by weight jojoba oil, 1-2% by weight sesame oil and 1-2% by weight olive oil as the vegetable oil, glycerin as the moisturizing agent, 1-5% by weight polyglyceryl-2- dipolyhydroxystearate and 0.5-2% by weight polyglyceryl-3-diisostearate as the surfactant with a HLB value in the range of 3-8, pentylene glycol as the preservative agent, citric acid as the pH regulating agent, mixture of propanediol and broomrape (orobanche rapum) extract as the active ingredient mixture, zinc stearate as the viscosity increasing agent, zinc sulphate heptahydrate as the stability increasing agent, 5-15% by weight caprylic/capric triglyceride and 3-10% by weight coco caprylate/caprate as the emollient, and 0.5-2% by weight vitamin B5 in the water phase and 0.1-1% by weight vitamin E in the
- the product according to the invention comprises 25-35% by weight water, 4-8% by weight vegetable oil, 3-10% by weight at least one moisturizing agent, 1.5-7% by weight surfactant with a HLB value in the range of 3-8, 1-5% by weight preservative agent, 0.1-0.5% by weight pH regulating agent, 0.3-1% by weight active ingredient mixture, 0.5-2% by weight viscosity increasing agent in the oil phase, 1-3% by weight stability increasing agent in the water phase, 8-25% by weight emollient in the oil phase and 0.6-3.5% by weight vitamin.
- Said embodiment comprises 1-2% by weight sunflower oil, 1-2% by weight jojoba oil, 1-2% by weight sesame oil and 1-2% by weight olive oil as the vegetable oil, glycerin as the moisturizing agent, 1-5% by weight polyglyceryl-2-dipolyhydroxystearate and 0.5-2% by weight polyglyceryl-3-diisostearate as the surfactant with a HLB value in the range of 3-8, pentylene glycol as the preservative agent, citric acid as the pH regulating agent, mixture of maltodextrin and lactobacillus ferment as the active ingredient mixture, zinc stearate as the viscosity increasing agent, zinc sulphate heptahydrate as the stability increasing agent, 5-15% by weight caprylic/capric triglyceride and 3-10% by weight coco caprylate/caprate as the emollient, and 0.5-2% by weight vitamin B5 and 0.1-1.5% by weight vitamin E as the vitamin.
- the skin product according to the invention is preferably a lotion.
- the invention further relates to a method for obtaining the skin product according to the invention wherein said method comprises the process steps of
- the product developed within the scope of the invention enables the generation of the ideal conditions necessary for regulating the moisture balance and the flora of the skin, meets the water requirement, eliminates the risk for the development of infection and thus strengthens the skin structure.
- the skin care product achieves said functions by means of its ingredients that are compatible with the skin pH of the babies as well, are natural and/or of natural origin and do not irritate the skin, and said product is suitable for use also in the care of the skin of the babies delivered before completing their development in the mother's womb.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
L'invention a pour objet un produit de soin de la peau, qui permet d'hydrater, de répondre aux besoins en eau, de réguler la flore et donc notamment de renforcer la structure de la peau sensible des bébés nés avant leur développement complet dans le ventre de la mère. Le produit, selon l'invention, comprend essentiellement une phase huileuse contenant les ingrédients oléosolubles, une phase aqueuse contenant les ingrédients hydrosolubles, et au moins un ingrédient actif et/ou un mélange d'ingrédients actifs assurant l'équilibre entre l'humidité et la flore de la peau tout en régulant cette dernière.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2020/21133 | 2020-12-21 | ||
TR2020/21133A TR202021133A1 (tr) | 2020-12-21 | 2020-12-21 | Ci̇lt yapisini güçlendi̇ren bi̇r ci̇lt bakim ürünü |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022139742A1 true WO2022139742A1 (fr) | 2022-06-30 |
Family
ID=82160026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2021/051259 WO2022139742A1 (fr) | 2020-12-21 | 2021-11-22 | Produit de soin de la peau renforçant la structure de la peau |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR202021133A1 (fr) |
WO (1) | WO2022139742A1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2873413A1 (fr) * | 2012-07-10 | 2015-05-20 | Shiseido Company, Ltd. | Produit cosmétique d'émulsion eau-dans-huile |
KR20160071921A (ko) * | 2014-12-12 | 2016-06-22 | 주식회사 풀무원 | 하이드롤라이즈드 호호바 에스터 오일을 포함하는 수중유형 가용화 화장료 조성물 |
JP2020158493A (ja) * | 2019-03-20 | 2020-10-01 | ジャパンメディック株式会社 | パンテノールを含有する油中水型(w/o型)クリーム |
-
2020
- 2020-12-21 TR TR2020/21133A patent/TR202021133A1/tr unknown
-
2021
- 2021-11-22 WO PCT/TR2021/051259 patent/WO2022139742A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2873413A1 (fr) * | 2012-07-10 | 2015-05-20 | Shiseido Company, Ltd. | Produit cosmétique d'émulsion eau-dans-huile |
KR20160071921A (ko) * | 2014-12-12 | 2016-06-22 | 주식회사 풀무원 | 하이드롤라이즈드 호호바 에스터 오일을 포함하는 수중유형 가용화 화장료 조성물 |
JP2020158493A (ja) * | 2019-03-20 | 2020-10-01 | ジャパンメディック株式会社 | パンテノールを含有する油中水型(w/o型)クリーム |
Also Published As
Publication number | Publication date |
---|---|
TR202021133A1 (tr) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4545990A (en) | Anti-acne composition | |
CN105030610B (zh) | 一种抗衰老组合物及其制备方法 | |
JPS60202806A (ja) | 色白化粧料 | |
ES2196333T5 (es) | Composiciones de aceites vegetales. | |
JPS5883648A (ja) | ラノリン酸銅及びそれを含む局所用組成物 | |
EP2174972A1 (fr) | Dérivé d'oxyde d'alkylène et préparation externe cutanée le contenant | |
FR2478485A1 (fr) | Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau | |
JP2000229832A (ja) | 皮膚外用剤 | |
US6284257B1 (en) | Cosmetic water emulsion containing at least one vegetable oil | |
JPH0725742A (ja) | 美白化粧料 | |
KR102359729B1 (ko) | 유화 제형의 끈적임 저감 및 투명도 향상용 화장료 조성물 | |
AU2015238586B2 (en) | Formulation for personal hygiene | |
IE46872B1 (en) | Dithranol composition for the treatment of psoriasis | |
KR20220058468A (ko) | 알칸디올, 및 카프릴릴글리세릴에터 또는 에틸헥실글리세린을 포함하는 피부 외용제용 보존제 및 이를 포함하는 화장료 조성물 | |
KR101945987B1 (ko) | 티로솔을 포함하는 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물 | |
JPH0751491B2 (ja) | 生薬配合乳化化粧料 | |
JP2021514970A (ja) | スキンケア効果を提供するための組成物及び使用方法 | |
JP2004307484A (ja) | 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品 | |
KR101460777B1 (ko) | 여드름 개선용 화장료 조성물 | |
WO2023078108A1 (fr) | Procédé d'amélioration de la stabilité de la p-hydroxyacétophénone dans une composition cosmétique | |
KR20110057815A (ko) | 버터류 포함 조성물 안정용 조성물 | |
WO2022139742A1 (fr) | Produit de soin de la peau renforçant la structure de la peau | |
GB2068225A (en) | Dermatological compositions containing hydrogen peroxide | |
JP4799102B2 (ja) | 油性皮膚用組成物 | |
KR20190042164A (ko) | 미생물의 번식을 억제하는 성분을 함유한 무방부제 물티슈용 조성물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21911722 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21911722 Country of ref document: EP Kind code of ref document: A1 |